Syneos Health Reports First Quarter 2022 Results
April 29, 2022 06:24 ET
|
Syneos Health, Inc.
Highlights Revenue for the first quarter of $1,336.3 million increased 10.5% on a reported basis and 11.7% on a constant currency basis year-over-year.Clinical Solutions net new business...
Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs
April 19, 2022 08:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the promotions of two senior...
Syneos Health Schedules First Quarter 2022 Earnings Call for Friday, April 29th, 2022
April 11, 2022 16:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health Reports Fourth Quarter and Full Year 2021 Results
February 17, 2022 06:10 ET
|
Syneos Health, Inc.
Highlights Fourth quarter revenue of $1,373.4 million increased 20.5% year-over-year.Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable out-of-pocket expenses,...
Syneos Health Schedules Fourth Quarter and Full Year 2021 Earnings Call for Thursday, February 17th, 2022
February 01, 2022 07:26 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health Appoints Two New Independent Directors
January 18, 2022 06:16 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has appointed two new...
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
January 11, 2022 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...
Syneos Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 09:06 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health Releases 2022 Health Trends
December 21, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released 2022 Health Trends: Insights for...
Syneos Health to Present at Upcoming Investor Conferences
November 11, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company is scheduled...